Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

Magnuson William J.; Lester-Coll Nataniel H.; Wu Abraham J.; Yang T. Jonathan; Lockney Natalie A.; Gerber Naamit K.; Beal Kathryn; Amini Arya; Patil Tejas; Kavanagh Brian D.; Camidge D. Ross; Braunstein Steven E.; Boreta Lauren C.; Balasubramanian Suresh K.; Ahluwalia Manmeet S.; Rana Niteshkumar G.; Attia Albert; Gettinger Scott N.; Contessa Joseph N.; Yu James B.; Chiang Veronica L.

首页> 外文期刊>Journal of Clinical Oncology >Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

【24h】

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

机译：酪氨酸激酶抑制剂 - 幼稚生长因子受体 - 突变体非小细胞肺癌中脑转移的管理：回顾性多制度分析

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose

机译：目的

著录项

来源
《Journal of Clinical Oncology》 |2017年第10期|共11页
作者
Magnuson William J.; Lester-Coll Nataniel H.; Wu Abraham J.; Yang T. Jonathan; Lockney Natalie A.; Gerber Naamit K.; Beal Kathryn; Amini Arya; Patil Tejas; Kavanagh Brian D.; Camidge D. Ross; Braunstein Steven E.; Boreta Lauren C.; Balasubramanian Suresh K.; Ahluwalia Manmeet S.; Rana Niteshkumar G.; Attia Albert; Gettinger Scott N.; Contessa Joseph N.; Yu James B.; Chiang Veronica L.;
展开▼
作者单位

Yale Sch Med New Haven CT USA;

Yale Sch Med New Haven CT USA;

Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

Mem Sloan Kettering Canc Ctr 1275 York Ave New York NY 10021 USA;

Univ Colorado Sch Med Denver CO USA;

Univ Colorado Sch Med Denver CO USA;

Univ Colorado Sch Med Denver CO USA;

Univ Colorado Sch Med Denver CO USA;

Univ Calif San Francisco San Francisco CA 94143 USA;

Univ Calif San Francisco San Francisco CA 94143 USA;

Cleveland Clin Fdn 9500 Euclid Ave Cleveland OH 44195 USA;

Cleveland Clin Fdn 9500 Euclid Ave Cleveland OH 44195 USA;

Vanderbilt Univ Sch Med Nashville TN 37212 USA;

Vanderbilt Univ Sch Med Nashville TN 37212 USA;

Yale Sch Med New Haven CT USA;

Yale Sch Med New Haven CT USA;

Yale Sch Med New Haven CT USA;

Yale Sch Med New Haven CT USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学;
关键词

相似文献

外文文献
中文文献
专利

1. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis [J] . Magnuson William J., Lester-Coll Nataniel H., Wu Abraham J., Journal of Clinical Oncology . 2017,第10期

机译：酪氨酸激酶抑制剂 - 幼稚生长因子受体 - 突变体非小细胞肺癌中脑转移的管理：回顾性多制度分析
2. Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors [J] . Si Sun, Hui Yu, Huijie Wang, OncoTargets and therapy . 2017,第3期

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗表皮生长因子受体突变型非小细胞肺癌患者 BIM 缺失多态性的探索性队列研究和荟萃分析

3. Retrospective, Multi-Institutional Analysis of Sequential Treatment of Brain Metastases in Treatment-Naive, Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer Should Not Define the Standard of Practice [J] . Chalmers Anna, Akerley Wallace Journal of Clinical Oncology . 2017,第20期

机译：回顾性，多制度分析治疗幼稚生长因子受体突变的非小细胞肺癌中脑转移的顺序治疗脑转移的多制度分析不应定义实践标准

4. QSAR Study of Quinazoline Derivatives as Inhibitor of Epidermal Growth Factor Receptor-Tyrosine Kinase (EGFR-TK) [C] . La Ode Aman, Widisusanti Abdulkadir, Julitha Geybie Rembet, International Conference on Computation for Science and Technology . 2015

机译：喹唑啉衍生物作为表皮生长因子受体 - 酪氨酸激酶（EGFR-TK）抑制剂的QSAR研究

5. Unanticipated Effects of Tyrosine Kinase Inhibitors on Vitamin D Receptor Expression and Gene Regulation In Epidermal Growth Factor Receptor-Mutated Non-Small Cell Lung Cancer. [D] . Timberlake, Alexandra F. 2017

机译：酪氨酸激酶抑制剂对表皮生长因子受体突变的非小细胞肺癌中维生素D受体表达和基因调控的意外影响。

6. Exploratory cohort study and meta-analysis of BIM deletion polymorphism in patients with epidermal growth factor receptor-mutant non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors [O] . Si Sun, Hui Yu, Huijie Wang, 2017

机译：表皮生长因子受体酪氨酸激酶抑制剂治疗表皮生长因子受体突变型非小细胞肺癌患者BIM缺失多态性的探索性队列研究和荟萃分析

7. Antacid Use and De Novo Brain Metastases in Patients with Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer Who Were Treated Using First-Line First-Generation Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors. [O] . Yu-Mu Chen, Chien-Hao Lai, Huang-Chih Chang, 2016

机译：使用一线第一代表皮生长因子受体酪氨酸激酶抑制剂治疗表皮生长因子受体突变非小细胞肺癌患者的抗酸药和De Novo脑转移。

1. 晚期非小细胞肺癌表皮生长因子受体敏感突变类型与表皮细胞生长因子受体酪氨酸激酶抑制剂疗效的回顾性研究 [J] . 李妍 ,王艳梅 ,陈旭 . 中华肺部疾病杂志（电子版） . 2016,第002期

2. 表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌获益后出现缓慢进展33例回顾性分析 [J] . 孙宇 ,秦海峰 ,郭瑞 . 中国临床医生 . 2014,第011期

3. 非小细胞肺癌骨转移患者用表皮生长因子受体酪氨酸激酶抑制剂治疗的预后因素分析 [J] . 田军 ,刘辉 ,姬巍 . 中国临床医学 . 2011,第005期

4. 放疗与酪氨酸激酶抑制剂治疗表皮生长因子受体突变型非小细胞肺癌脑转移的研究进展 [J] . 罗鹏辉 ,黄剑锋 ,莫敦昌 . 广西医学 . 2020,第013期

5. 表皮生长因子受体酪氨酸激酶抑制剂联合全脑放疗治疗非小细胞肺癌脑转移患者临床疗效 [J] . 韩海林 . 实用癌症杂志 . 2019,第005期

6. 扶正治癌中药组方联合表皮生长因子受体酪氨酸激酶抑制剂治疗晚期非小细胞肺癌的临床疗效 [C] . 朱伟嵘 ,项轶 ,高蓓莉 . 中国民族医药学会肺病分会第三届学术交流年会、上海市中西医结合学会呼吸病专业委员会学术交流年会、上海市中医药学会呼吸病分会换届及学术交流年会 . 2017

7. 晚期非小细胞肺癌血浆表皮生长因子受体（EGFR）基因突变与表皮生长因子受体酪氨酸激酶抑制剂（EGFR-TKIs）疗效的相关性分析 [A] . 林立平 . 2008

1. 表皮生长因子受体酪氨酸激酶抑制剂的筛选方法及由其筛选的抑制剂 [P] . 中国专利： CN102341708B . 2014.02.19

2. 含有蛋白激酶B抑制剂和表皮生长因子受体酪氨酸激酶抑制剂的药物组合物及其应用 [P] . 中国专利： CN101653606B . 2013.02.13

3. A METHOD FOR INHIBITION OF TYROSINE KINASE OF EPIDERMAL GROWTH FACTOR RECEPTOR (VARIANTS), BICYCLIC COMPOUNDS OF PYRIMIDIN, A PHARMACEUTICAL COMPOSITION HAVING ACTIVITY INHIBING THE EPIDERMAL GROWTH FACTOR RECEPTOR TYROSINE KINASE, AND A COMPOSITION HAVING CONTRACEPTIVE ACTIVITY [P] . 外国专利： UA62028C2 . 2003-12-15

机译：抑制表皮生长因子受体（变体）的酪氨酸激酶，吡嘧啶的双环化合物，具有抑制表皮生长因子受体酪氨酸激酶活性的药物组合物和复合物的方法

4. METHODS OF INHIBITION OF TYROSINE KINASE ACTIVITY IN EPIDERMAL GROWTH FACTOR RECEPTORS, BICYCLIC PYRIMIDINE DERIVATIVES, PHARMACEUTICAL COMPOSITION SHOWING ACTIVITY INHIBITING ACTIVITY OF TYROSINE KINASE IN EPIDERMAL GROWTH FACTOR RECEPTORS AND COMPOSITION ELICITING CONTRACEPTIVE EFFECT [P] . 外国专利： RU2174980C2 . 2001-10-20

机译：抑制表皮生长因子受体，双环嘧啶衍生物，药物成分显示活性抑制酪氨酸激酶活性的方法在表皮生长因子受体和成分中抑制酪氨酸激酶活性

5. METHOD FOR TREATING EPIDERMAL GROWTH FACTOR RECEPTOR-DRIVEN CANCERS WITH PROTEIN KINASE C INHIBITORS IN COMBINATION WITH AN EGFR-TYROSINE KINASE INHIBITOR [P] . 外国专利： WO2020198469A1 . 2020-10-01

机译：结合蛋白酪氨酸激酶抑制剂和蛋白激酶C抑制剂治疗表皮生长因子受体驱动的癌症的方法

相关主题

Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naive Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis

摘要

著录项

相似文献

相关主题

期刊订阅